Submission Details
| 510(k) Number | K041869 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 09, 2004 |
| Decision Date | November 18, 2004 |
| Days to Decision | 132 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Statement |
K041869 is an FDA 510(k) clearance for the SELF RETAINING BICANALICULUS INTUBATION SET, a Lacrimal Stents And Intubation Sets, submitted by Fci Ophthalmics, Inc. (Marshfield Hills, US). The FDA issued a Cleared decision on November 18, 2004, 132 days after receiving the submission on July 9, 2004. This device falls under the Ophthalmic review panel.
| 510(k) Number | K041869 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 09, 2004 |
| Decision Date | November 18, 2004 |
| Days to Decision | 132 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Statement |
| Product Code | OKS — Lacrimal Stents And Intubation Sets |
| Device Class | — |
| Definition | Lacrimal Stents And Intubations Sets Are Intended To Repair The Lacrimal Drainage System. Lacrimal Stents And Intubations Sets Are Indicated For, But Limited To, The Treatment Of Epiphora In Infants And Adults; Canalicular Pathologies Such As Stenosis; Obstruction Or Laceration; And Conditions Requiring Dacryocystorhinostomy (conventional Or Laser); Or Imperforation Of The Nasolacrimal Duct In An Infant. |